When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more

Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business.

Parmley is most noted for his research on the harmful effects of secondhand smoke, hemodynamics and new therapies for heart failure. 

A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context. 

This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected. 

The engineers behind this new device envision a future where patients wear a single postage stamp-sized sticker that images and stimulates the heart. 

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic. 

Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

This new catheter-based device for lymphatic drainage showed early potential to be an effective treatment option for acute decompensated heart failure.

Researchers project that the global healthcare workforce will need approximately 750,000 more radiologists by 2050. 

The data on medical coverage rates comes from the 2025 National Health Interview Survey, with data being released by the CDC twice a year. Numbers from last year show that 28 million people have no health insurance.